New topical microemulsions of etofenamate as sufficient management of osteoarthritis

BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES(2022)

Cited 1|Views0
No score
Abstract
In this study, microemulsions containing etofenamate were prepared and evaluated as dermal delivery carriers. The developed microemulsions consist of oleic acid, Span 80, Tween 20, Cremophor EL, Transcutol and ethanol. The percentage of etofenamate loading in the microemulsions was 5% (w/w). The characterization of formulations included droplet size, zeta potential, pH, conductivity, PDI, refractive index and viscosity. Moreover, ex vivo penetration study was carried out using mice abdominal skin. The developed formulations were analyzed for their cytotoxicity via MTT assay and tested for their anti-inflammatory properties opposed to LPS-stimulated nitrite production in RAW 264.7 cells. As ideal formulation, M2(ETF), was chosen due to its greater permeation, lower penetration as well as higher anti-inflammatory activity compared to other microemulsions.
More
Translated text
Key words
Etofenamate, Nonsteroidal anti-inflammatory drug, Microemulsion, Ex vivo, Cytotoxicity, Anti-inflammatory activity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined